链激酶的英文

• staphylokinase
• streptokinase,sk

• "链"英文翻译    chain
• "激酶"英文翻译    kinase
• "抗链激酶" 英文翻译 :    antistreptokinase
• "链道酶-链激酶" 英文翻译 :    sd-sk
• "链激酶,溶栓酶" 英文翻译 :    streptococcal fibrinolysin
• "链激酶-链道酶" 英文翻译 :    sk-sd
• "链激酶测量" 英文翻译 :    streptokinase measurement
• "链激酶制剂" 英文翻译 :    streptokinase preparation
• "溶栓酶，链激酶" 英文翻译 :    streptokinase(sk)
• "重组链激酶" 英文翻译 :    recombinant streptokinase，rsk
• "链球菌dna酶-链激酶,链道酶-链激酶" 英文翻译 :    sd-sk; streptodornase-streptokinase
• "链激酶粉针剂" 英文翻译 :    streptokinase
• "链激酶注射液" 英文翻译 :    streptokinase injection
• "链球菌激酶,链激酶" 英文翻译 :    streptokinase
• "肌球蛋白轻链激酶" 英文翻译 :    myosin light chain kinase
• "链激酶-链道酶,双链酶" 英文翻译 :    sk-sd
• "链激酶-链道酶反应" 英文翻译 :    sk-sd reaction; streptokinase-streptodornase reaction
• "链激酶一链道酶" 英文翻译 :    varidase
• "链球菌dna酶-链激酶" 英文翻译 :    sd-sk
• "双链酶,链激酶-链道酶" 英文翻译 :    sksd; striptokinase-streptodornase; sttreptokinase-streptodornase
• "抗链激酶,抗链球菌激酶" 英文翻译 :    anti-streptokinase
• "链激酶,溶栓酶,链球菌激酶" 英文翻译 :    streptokinase
• "药品商品名〗注射用重组链激酶" 英文翻译 :    recombinant streptokinase for injection
• "链激霉" 英文翻译 :    streptase
• "激酶" 英文翻译 :    kinase

• Myosin light chain kinase
  肌球蛋白轻链激酶
• We conducted a trial to clarify the therapeutic role of intrapleural streptokinase
  我们进行了一项试验，以阐明胸膜腔内应用链激酶的治疗作用。
• Therapeutic efficacy of recombinant streptokinase and urokinase in the treatment of acute myocardial infarction
  重组链激酶与尿激酶治疗急性心肌梗死的疗效
• Intrapleural streptokinase for pleural infection a step forward in managing pleural effusions
  胸膜腔内滴注链激酶治疗胸膜腔感染这是胸膜腔积液治疗的进步吗
• Acute myocardial infarction treated by thrombolysis with recombinant streptorinase : a report of 22 cases
  重组链激酶静脉溶栓治疗急性心肌梗死的疗效观察附22例报告
• The comparison of the repass rate between homemade recombined streptokinase and urokinase in thrombolytic therapy of acute myocardial infarction
  国产重组链激酶与尿激酶在急性心肌梗死溶栓中的血管再通率的比较
• Conclusions the intrapleural administration of streptokinase does not improve mortality , the rate of surgery , or the length of the hospital stay among patients with pleural infection
  结论在胸膜感染的病人中，链激酶胸膜腔内给药不能改善死亡率、手术率或住院时间的长短。
• The systemic administration of heparin , warfarin or streptokinase is determined to have a thrombolytic effect but risk systemic or ocular bleeding and appeare to be unhelpul for improving visual acuity
  全身应用肝素、华法令或链激酶溶栓药物已被证实对提高视力没有明确帮助，并且存在全身或局部出血的风险。
• All the currently used thrombolytic agents are plasminogen activators , which are very efficient in restoring the blood flow . they can convert plasminogen into plasmin and thus degrade fibrin . despite the widespread use of established thrombolytic agents such as streptokinase , t - pa and u - pa , all these agents suffer from a number of inadequacies including resistance to reperfusion , occurrence of coronary reocclusion and bleeding complications
  介绍了国内外溶栓剂蛋白质工程方面的新进展，主要涉及了组织型纤溶酶原激活剂t - pa尿激酶型纤溶酶原激活剂u - pa链激酶sk葡萄球菌激酶sak dspa及tsv - pa的研究进展。

• 链激酶的泰文
• 链激酶的法语：Streptokinase
• 链激酶的日语：ストレプトキナーゼ
• 链激酶的俄语：Стрептокиназа
• 链激酶的阿拉伯语：ستربتوكاينيز;
• 链激酶的印尼文：streptokinase;